Detalles de la búsqueda
1.
A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease.
Eur Heart J
; 37(27): 2105-14, 2016 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-27130705
2.
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
JAMA
; 314(9): 884-94, 2015 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26325557
3.
Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy.
Am J Nephrol
; 40(6): 572-81, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25591469
4.
Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone (BAY 94-8862) in Individuals With Renal Impairment.
Clin Pharmacol Drug Dev
; 5(6): 488-501, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27431783
5.
Pharmacokinetics, safety and tolerability of the novel, selective mineralocorticoid receptor antagonist finerenone - results from first-in-man and relative bioavailability studies.
Fundam Clin Pharmacol
; 30(2): 172-84, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26604072
6.
Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease.
Eur J Heart Fail
; 17(2): 224-32, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25678098
Resultados
1 -
6
de 6
1
Próxima >
>>